2023 China Alzheimer’s disease: facts and figures
Abstract
In China, the aging population and the increasing incidence of Alzheimer's disease (AD) and other dementias have emerged as major medical concerns. Extensive research and new technologies on AD have provided possibilities for early intervention, including emerging biomarkers for detection and new drugs with disease-modifying therapy. This report includes a large amount of facts and figures to describe the understanding of patients and their families about the disease, discuss the problems they encounter in the current medical environment, and outline potential difficulties in clinical diagnosis and treatment status. Furthermore, people’s concerns, the overall effect on caregivers, and the development of AD treatment are presented in this report. Overall, to increase public awareness of the disease, this report suggests early detection, screening, and intervention for AD while calling on all sectors to work together to help AD patients.
References
- Alzheimer's disease facts and figures. (2023). Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 19(4), 1598-1695. https://doi.org/10.1002/alz.13016
- Administration, N. M. P. (2023). Release of drug approval document service information.https://www.nmpa.gov.cn/zwfw/sdxx/sdxxyp/yppjfb/20230915152000153.html(Acess in 2023.10.15)
- Arevalo-Rodriguez, I., Smailagic, N., Roqué-Figuls, M., Ciapponi, A., Sanchez-Perez, E., Giannakou, A., Pedraza, O. L., Bonfill Cosp, X., & Cullum, S. (2021). Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). The Cochrane Database of Systematic Reviews, 7(7), CD010783. https://doi.org/10.1002/14651858.CD010783.pub3
- Avila, J., Lucas, J. J., Perez, M., & Hernandez, F. (2004). Role of tau protein in both physiological and pathological conditions. Physiological Reviews, 84(2), 361-384. https://pubmed.ncbi.nlm.nih.gov/15044677
- Cacace, R., Sleegers, K., & Van Broeckhoven, C. (2016). Molecular genetics of early-onset Alzheimer's disease revisited. Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 12(6), 733-748. https://doi.org/10.1016/j.jalz.2016.01.012
- Chen, Y., Denny, K. G., Harvey, D., Farias, S. T., Mungas, D., DeCarli, C., & Beckett, L. (2017). Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 13(4), 399-405. https://doi.org/10.1016/j.jalz.2016.07.151
- Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., . . . Selkoe, D. J. (1997). Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med, 3(1), 67-72. https://doi.org/10.1038/nm0197-67
- Clark, C. M., Schneider, J. A., Bedell, B. J., Beach, T. G., Bilker, W. B., Mintun, M. A., Pontecorvo, M. J., Hefti, F., Carpenter, A. P., Flitter, M. L., Krautkramer, M. J., Kung, H. F., Coleman, R. E., Doraiswamy, P. M., Fleisher, A. S., Sabbagh, M. N., Sadowsky, C. H., Reiman, E. P., Zehntner, S. P., & Skovronsky, D. M. (2011). Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA, 305(3), 275-283. https://doi.org/10.1001/jama.2010.2008
- Crous-Bou, M., Minguillón, C., Gramunt, N., & Molinuevo, J. L. (2017). Alzheimer's disease prevention: from risk factors to early intervention. Alzheimer's Research & Therapy, 9(1), 71. https://doi.org/10.1186/s13195-017-0297-z
- De Roeck, E. E., De Deyn, P. P., Dierckx, E., & Engelborghs, S. (2019). Brief cognitive screening instruments for early detection of Alzheimer's disease: a systematic review. Alzheimer's Research & Therapy, 11(1), 21. https://doi.org/10.1186/s13195-019-0474-3
- Gao, F., Dai, L., Wang, Q., Liu, C., Deng, K., Cheng, Z., Lv, X., Wu, Y., Zhang, Z., Tao, Q., Yuan, J., Li, S., Wang, Y., Su, Y., Cheng, X., Ni, J., Wu, Z., Zhang, S., Shi, J., & Shen, Y. (2023). Blood-based biomarkers for Alzheimer's disease: a multicenter-based cross-sectional and longitudinal study in China. Science Bulletin, 68(16), 1800-1808. https://doi.org/10.1016/j.scib.2023.07.009
- Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. (2019). The Lancet. Neurology, 18(1). https://doi.org/10.1016/S1474-4422(18)30403-4
- Hampel, H., Shaw, L. M., Aisen, P., Chen, C., Lleó, A., Iwatsubo, T., Iwata, A., Yamada, M., Ikeuchi, T., Jia, J., Wang, H., Teunissen, C. E., Peskind, E., Blennow, K., Cummings, J., & Vergallo, A. (2022). State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 18(1), 159-177. https://doi.org/10.1002/alz.12372
- Hardy, J. A., & Higgins, G. A. (1992). Alzheimer's disease: the amyloid cascade hypothesis. Science, 256(5054), 184-185. https://doi.org/10.1126/science.1566067
- Huang, L.-K., Kuan, Y.-C., Lin, H.-W., & Hu, C.-J. (2023). Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update. Journal of Biomedical Science, 30(1), 83. https://doi.org/10.1186/s12929-023-00976-6
- Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., Debnath, M. L., Hope, C. E., Isanski, B. A., Hamilton, R. L., & DeKosky, S. T. (2008). Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain : a Journal of Neurology, 131(Pt 6), 1630-1645. https://doi.org/10.1093/brain/awn016
- Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J. L., Montine, T., Phelps, C., Rankin, K. P., Rowe, C. C., Scheltens, P., Siemers, E., Snyder, H. M., & Sperling, R. (2018). NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 14(4), 535-562. https://doi.org/10.1016/j.jalz.2018.02.018
- Janelidze, S., Pannee, J., Mikulskis, A., Chiao, P., Zetterberg, H., Blennow, K., & Hansson, O. (2017). Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment. JAMA Neurology, 74(12), 1492-1501. https://doi.org/10.1001/jamaneurol.2017.2814
- Jia, J., Wei, C., Chen, S., Li, F., Tang, Y., Qin, W., Zhao, L., Jin, H., Xu, H., Wang, F., Zhou, A., Zuo, X., Wu, L., Han, Y., Han, Y., Huang, L., Wang, Q., Li, D., Chu, C., . . . Gauthier, S. (2018). The cost of Alzheimer's disease in China and re-estimation of costs worldwide. Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 14(4), 483-491. https://doi.org/10.1016/j.jalz.2017.12.006
- Jucker, M., & Walker, L. C. (2023). Alzheimer's disease: From immunotherapy to immunoprevention. Cell, 186(20), 4260-4270. https://doi.org/10.1016/j.cell.2023.08.021
- Karki, H. P., Jang, Y., Jung, J., & Oh, J. (2021). Advances in the development paradigm of biosample-based biosensors for early ultrasensitive detection of alzheimer's disease. Journal of Nanobiotechnology, 19(1), 72. https://doi.org/10.1186/s12951-021-00814-7
- Laske, C., Sohrabi, H. R., Frost, S. M., López-de-Ipiña, K., Garrard, P., Buscema, M., Dauwels, J., Soekadar, S. R., Mueller, S., Linnemann, C., Bridenbaugh, S. A., Kanagasingam, Y., Martins, R. N., & O'Bryant, S. E. (2015). Innovative diagnostic tools for early detection of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 11(5), 561-578. https://doi.org/10.1016/j.jalz.2014.06.004
- Liu, J., Wang, L. N., & Tan, J. P. (2013). Dementia in China: current status. Neurology, 81(12), 1077-1078. https://doi.org/10.1212/WNL.0b013e3182a4a3cb
- Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., Lindström, J., Mangialasche, F., Paajanen, T., Pajala, S., Peltonen, M., Rauramaa, R., Stigsdotter-Neely, A., Strandberg, T., Tuomilehto, J., . . . Kivipelto, M. (2015). A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet (London, England), 385(9984), 2255-2263. https://doi.org/10.1016/S0140-6736(15)60461-5
- Palmqvist, S., Janelidze, S., Quiroz, Y. T., Zetterberg, H., Lopera, F., Stomrud, E., Su, Y., Chen, Y., Serrano, G. E., Leuzy, A., Mattsson-Carlgren, N., Strandberg, O., Smith, R., Villegas, A., Sepulveda-Falla, D., Chai, X., Proctor, N. K., Beach, T. G., Blennow, K., . . . Hansson, O. (2020). Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA, 324(8), 772-781. https://doi.org/10.1001/jama.2020.12134
- Ren, R., Qi, J., Lin, S., Liu, X., Yin, P., Wang, Z., Tang, R., Wang, J., Huang, Q., Li, J., Xie, X., Hu, Y., Cui, S., Zhu, Y., Yu, X., Wang, P., Zhu, Y., Wang, Y., Huang, Y., . . . Wang, G. (2022). The China Alzheimer Report 2022. General Psychiatry, 35(1), e100751. https://doi.org/10.1136/gpsych-2022-100751
- Ross, E. L., Weinberg, M. S., & Arnold, S. E. (2022). Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US. JAMA Neurology, 79(5), 478-487. https://doi.org/10.1001/jamaneurol.2022.0315
- Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chetelat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021). Alzheimer's disease. Lancet, 397(10284), 1577-1590. https://doi.org/10.1016/S0140-6736(20)32205-4
- Sirkis, D. W., Bonham, L. W., Johnson, T. P., La Joie, R., & Yokoyama, J. S. (2022). Dissecting the clinical heterogeneity of early-onset Alzheimer's disease. Molecular Psychiatry, 27(6), 2674-2688. https://doi.org/10.1038/s41380-022-01531-9
- van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., Froelich, L., Katayama, S., Sabbagh, M., Vellas, B., Watson, D., Dhadda, S., Irizarry, M., Kramer, L. D., & Iwatsubo, T. (2022). Lecanemab in Early Alzheimer's Disease. N Engl J Med. https://doi.org/10.1056/NEJMoa2212948
- Veitch, D. P., Weiner, M. W., Miller, M., Aisen, P. S., Ashford, M. A., Beckett, L. A., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Landau, S. M., Morris, J. C., Nho, K. T., Nosheny, R., Okonkwo, O., Perrin, R. J., Petersen, R. C., Rivera Mindt, M., Saykin, A., . . . Tosun, D. (2023). The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. https://doi.org/10.1002/alz.13449
- Wang, H.-L., Tang, R., Ren, R.-J., Dammer, E. B., Guo, Q.-H., Peng, G.-P., Cui, H.-L., Zhang, Y.-M., Wang, J.-T., Xie, X.-Y., Huang, Q., Li, J.-P., Yan, F.-H., Chen, S.-D., He, N.-Y., & Wang, G. (2022). Speech silence character as a diagnostic biomarker of early cognitive decline and its functional mechanism: a multicenter cross-sectional cohort study. BMC Medicine, 20(1), 380. https://doi.org/10.1186/s12916-022-02584-x
- Wang J-T, W. G. (10th July, 2023.). Investigation and Research on the Current Situation of Patients with Cognitive Impairment. https://mp.weixin.qq.com/s/M1xpv3osiEbkvxtFn0AXrQ (Acess in 2023.10.15)
- Wang, X., Huang, W., Su, L., Xing, Y., Jessen, F., Sun, Y., Shu, N., & Han, Y. (2020). Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease. Molecular Neurodegeneration, 15(1), 55. https://doi.org/10.1186/s13024-020-00395-3
- Wang, Y.-Q., Jia, R.-X., Liang, J.-H., Li, J., Qian, S., Li, J.-Y., & Xu, Y. (2019). Dementia in China (2015-2050) estimated using the 1% population sampling survey in 2015. Geriatrics & Gerontology International, 19(11), 1096-1100. https://doi.org/10.1111/ggi.13778
- Weiner, M. F., Hynan, L. S., Bret, M. E., & White, C. (2005). Early behavioral symptoms and course of Alzheimer's disease. Acta Psychiatrica Scandinavica, 111(5), 367-371. https://pubmed.ncbi.nlm.nih.gov/15819730
- Xiao, Z., Wu, W., Ma, X., Liang, X., Lu, J., Zheng, L., Ding, S., Lei, Q., Luo, J., Chen, K., Ding, D., & Zhao, Q. (2022). Plasma Aβ42/Aβ40 and p-tau181 Predict Long-Term Clinical Progression in a Cohort with Amnestic Mild Cognitive Impairment. Clinical Chemistry, 68(12), 1552-1563. https://doi.org/10.1093/clinchem/hvac149
- Zhu, Y., Yu, X., & Wang, G. (2023). Suggestions for home care of people with dementia based on community support. Chinese Journal of Alzheimer's Disease and Related Disorders, 6(01), 77-84.
How to Cite
How to Cite
Search Panel
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Google Scholar
Pubmed
JDMFS Journal
Downloads
Article Details
Most Read This Month
License
Copyright (c) 2023 Jinwen Xiao, Jianping Li, Jintao Wang, Xingyu Zhang, Cong Wang, Guoping Peng, Hua Hu, Huayan Liu, Jun Liu, Lu Shen, Nan Zhang, Ning Yan, Qinying Ma, Wanzhong Xu, Zhengluan Liao, Rujing Ren, Mingwei Wang, Enyan Yu, Jinzhou Tian, Huali Wang, Yong’an Sun, Hengge Xie , Gang Wang
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.